SCHEMBL22188744

SCHEMBL22188744

SN1C[CH]OCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL37779 0.67
SCHEMBL29129459 0.62
SCHEMBL1208220 0.62
SCHEMBL3389306 0.62
SCHEMBL21221329 0.62
SCHEMBL19948717 0.62
SCHEMBL28770740 0.59 HRH3 (0.31)
SCHEMBL79194 0.59
Fluoride SCHEMBL28867502 0.59 MGLL (0.42)
SCHEMBL15365152 0.46

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103965107-A 2-aryl-substituted quinoline compounds and application thereof UNIV SHENYANG PHARMACEUTICAL 2014-08-06 CN claimed
US-20200216434-A1 BENZOFURAN UREAS OR CARBAMATES AND HETEROAROMATIC ANALOGUES THEREOF FOR USE IN THERAPY EUROPEAN MOLECULAR BIOLOGY LABORATORY (DE) 2020-07-09 US disclosed
CN-103965107-A 2-aryl-substituted quinoline compounds and application thereof UNIV SHENYANG PHARMACEUTICAL 2014-08-06 CN disclosed
CN-101903349-B 4- (4-pyridinyl) -benzamides and their use as ROCK activity modulators ABBOTT GMBH & CO KG 2014-01-08 CN disclosed
CN-102076690-A Protein kinase inhibitors VERTEX PHARMA 2011-05-25 CN disclosed
CN-102076691-A Protein kinase inhibitors VERTEX PHARMA 2011-05-25 CN disclosed
CN-101903349-A 4- (4-pyridinyl) -benzamides and their use as ROCK activity modulators ABBOTT GMBH & CO KG 2010-12-01 CN disclosed
CN-100577658-C Quinazoline derivatives ASTRAZENECA AB 2010-01-06 CN disclosed
CN-1886399-A Quinazoline derivatives ASTRAZENECA AB (SE) 2006-12-27 CN disclosed